Teclistamab in Relapsed or Refractory Multiple Myeloma | NEJM - nejm.org

6/5/2022 12:00:00 AM2 years 10 months ago

Original Article from The New England Journal of Medicine — Teclistamab in Relapsed or Refractory Multiple Myeloma

From the Hematology Clinic, University Hospital Hôtel-Dieu, Nantes (P.M.), Service dHématologie Clinique, Centre Hospitalier Lyon Sud, Pierre-Bénite (L.K.), and Service dHématologie et Thérapie Cellu… [+2555 chars]

full article...